Chimin Health Management Hits Day High with Strong 6.26% Intraday Surge

Chimin Health Management Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.26% on September 30, 2025. The stock reached an intraday high of CNY 12.23, marking a notable moment in its trading activity. This performance stands in contrast to the China Shanghai Composite, which only increased by 0.9% on the same day.
Despite this daily gain, Chimin Health's longer-term performance metrics reveal a more complex picture. Over the past year, the stock has surged by 87.17%, significantly outperforming the China Shanghai Composite's 25.1% increase. However, the company has faced challenges, with a year-to-date performance of 67.6% and a troubling five-year decline of 66.82%.

Financially, Chimin Health is characterized by a high debt-to-equity ratio of 0.24, indicating a reliance on debt financing. The company has reported negative results in recent quarters, with net sales declining by 21.76% and a pre-tax profit drop of 69.12%. These factors contribute to a cautious outlook on the company's financial health, despite today's positive trading activity.